The Cooper Companies, Inc. (COO) EV/FCF Ratio: 27.32x
Is The Cooper Companies, Inc.’s EV/FCF ratio high or low?
The Cooper Companies, Inc.'s EV/FCF ratio of 27.32x is 59% below its 5-year average of 66.14x, near the low end of its 5-year range (26.95x–178.47x).
As of Sunday, June 14, 2026. 31.35% below its 12-month average of 39.79x.
COO EV/FCF Ratio Chart
COO Average EV/FCF Ratio Chart
COO Current vs Average EV/FCF Ratio Chart
COO EV/FCF Ratio Metrics
EV/FCF RATIO
27.32x
EV/FCF RATIO AVG TTM
39.79x
EV/FCF RATIO AVG 3Y
81.71x
EV/FCF RATIO AVG 5Y
66.14x
EV/FCF RATIO AVG 10Y
56.91x
EV/FCF RATIO AVG 15Y
48.73x
EV/FCF RATIO AVG 20Y
55.66x
CURRENT VS TTM AVG
-31.35%
CURRENT VS 3Y AVG
-66.57%
CURRENT VS 5Y AVG
-58.69%
CURRENT VS 10Y AVG
-52.00%
CURRENT VS 15Y AVG
-43.93%
CURRENT VS 20Y AVG
-50.92%
COO Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 27.32x | 39.79x | 81.71x | 66.14x |
| Solventum Corporation (SOLV) | $13.66B | N/A | 157.09x | 88.54x | 88.54x |
| Align Technology, Inc. (ALGN) | $12.52B | 16.87x | 17.70x | 29.55x | 38.89x |
| Baxter International Inc. (BAX) | $10.77B | 25.79x | 67.49x | 51.63x | 47.32x |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | 66.60x | 67.40x | 78.57x | 42.55x |
| Hologic, Inc. (HOLX) | $16.97B | 17.53x | 16.94x | 18.67x | 15.16x |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 30.78x | 21.33x | 29.09x | 35.21x |
| Tempus AI, Inc. (TEM) | $8.35B | N/A | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 24.02x | 25.10x | 43.42x | 51.09x |
| Moderna, Inc. (MRNA) | $19.80B | N/A | 26.90x | 26.23x | 26.23x |
Cash Flow Valuation Comparison
EV/FCF
27.3x
P/FCF
23.2x
FCF Yield
4.30%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
The Cooper Companies, Inc. EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. EV/FCF Ratio FAQ
- What is the EV/FCF ratio for The Cooper Companies, Inc. (COO)?
- The EV/FCF ratio for COO stock is 27.32x.
- Is The Cooper Companies, Inc.'s EV/FCF ratio high or low?
- The Cooper Companies, Inc.'s EV/FCF ratio of 27.32x is 59% below its 5-year average of 66.14x, near the low end of its 5-year range (26.95x–178.47x).
- What is the TTM average EV/FCF ratio for The Cooper Companies, Inc. (COO)?
- The TTM average EV/FCF ratio for COO stock is 39.79x.
- What is the 3Y average EV/FCF ratio for The Cooper Companies, Inc. (COO)?
- The 3Y average EV/FCF ratio for COO stock is 81.71x.
- What is the 5Y average EV/FCF ratio for The Cooper Companies, Inc. (COO)?
- The 5Y average EV/FCF ratio for COO stock is 66.14x.
- What is the 10Y average EV/FCF ratio for The Cooper Companies, Inc. (COO)?
- The 10Y average EV/FCF ratio for COO stock is 56.91x.
- What is the 15Y average EV/FCF ratio for The Cooper Companies, Inc. (COO)?
- The 15Y average EV/FCF ratio for COO stock is 48.73x.
- What is the 20Y average EV/FCF ratio for The Cooper Companies, Inc. (COO)?
- The 20Y average EV/FCF ratio for COO stock is 55.66x.
The Cooper Companies, Inc. EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-12 | 27.32x |
| 2026-06-11 | 27.19x |
| 2026-06-10 | 27.25x |
| 2026-06-09 | 27.57x |
| 2026-06-08 | 26.95x |
| 2026-06-05 | 27.13x |
| 2026-06-04 | 29.67x |
| 2026-06-03 | 29.00x |
| 2026-06-02 | 28.66x |
| 2026-06-01 | 28.94x |
| 2026-05-29 | 29.35x |
| 2026-05-28 | 29.28x |
| 2026-05-27 | 29.18x |
| 2026-05-26 | 29.67x |
| 2026-05-22 | 29.88x |
| 2026-05-21 | 30.00x |
| 2026-05-20 | 29.56x |
| 2026-05-19 | 29.44x |
| 2026-05-18 | 29.24x |
| 2026-05-15 | 28.71x |
| 2026-05-14 | 29.01x |
| 2026-05-13 | 28.65x |
| 2026-05-12 | 28.84x |
| 2026-05-11 | 28.45x |
| 2026-05-08 | 28.86x |
| 2026-05-07 | 29.31x |
| 2026-05-06 | 29.31x |
| 2026-05-05 | 29.36x |
| 2026-05-04 | 29.47x |
| 2026-05-01 | 29.81x |
| 2026-04-30 | 30.02x |
| 2026-04-29 | 29.40x |
| 2026-04-28 | 30.10x |
| 2026-04-27 | 30.60x |
| 2026-04-24 | 30.63x |
| 2026-04-23 | 30.84x |
| 2026-04-22 | 31.63x |
| 2026-04-21 | 31.78x |
| 2026-04-20 | 32.65x |
| 2026-04-17 | 32.89x |
| 2026-04-16 | 32.62x |
| 2026-04-15 | 32.98x |
| 2026-04-14 | 33.51x |
| 2026-04-13 | 33.55x |
| 2026-04-10 | 33.35x |
| 2026-04-09 | 33.45x |
| 2026-04-08 | 33.56x |
| 2026-04-07 | 32.73x |
| 2026-04-06 | 32.98x |
| 2026-04-02 | 32.93x |
| 2026-04-01 | 33.44x |
| 2026-03-31 | 33.47x |
| 2026-03-30 | 32.59x |
| 2026-03-27 | 32.77x |
| 2026-03-26 | 33.48x |
| 2026-03-25 | 33.45x |
| 2026-03-24 | 33.06x |
| 2026-03-23 | 32.96x |
| 2026-03-20 | 32.85x |
| 2026-03-19 | 33.15x |
| 2026-03-18 | 33.33x |
| 2026-03-17 | 33.69x |
| 2026-03-16 | 33.28x |
| 2026-03-13 | 32.83x |
| 2026-03-12 | 33.47x |
| 2026-03-11 | 34.37x |
| 2026-03-10 | 34.63x |
| 2026-03-09 | 35.20x |
| 2026-03-06 | 35.49x |
| 2026-03-05 | 42.80x |
| 2026-03-04 | 43.61x |
| 2026-03-03 | 44.24x |
| 2026-03-02 | 44.50x |
| 2026-02-27 | 44.38x |
| 2026-02-26 | 44.54x |
| 2026-02-25 | 44.29x |
| 2026-02-24 | 44.33x |
| 2026-02-23 | 44.05x |
| 2026-02-20 | 44.56x |
| 2026-02-19 | 44.39x |
| 2026-02-18 | 44.26x |
| 2026-02-17 | 43.59x |
| 2026-02-13 | 44.07x |
| 2026-02-12 | 43.48x |
| 2026-02-11 | 44.10x |
| 2026-02-10 | 43.42x |
| 2026-02-09 | 43.38x |
| 2026-02-06 | 43.66x |
| 2026-02-05 | 42.75x |
| 2026-02-04 | 43.12x |
| 2026-02-03 | 42.40x |
| 2026-02-02 | 43.00x |
| 2026-01-30 | 43.33x |
| 2026-01-29 | 42.87x |
| 2026-01-28 | 42.92x |
| 2026-01-27 | 43.02x |
| 2026-01-26 | 43.12x |
| 2026-01-23 | 43.29x |
| 2026-01-22 | 43.98x |
| 2026-01-21 | 43.86x |
| 2026-01-20 | 42.98x |
| 2026-01-16 | 43.79x |
| 2026-01-15 | 43.76x |
| 2026-01-14 | 43.48x |
| 2026-01-13 | 43.48x |
| 2026-01-12 | 44.18x |
| 2026-01-09 | 44.28x |
| 2026-01-08 | 44.13x |
| 2026-01-07 | 44.49x |
| 2026-01-06 | 44.68x |
| 2026-01-05 | 43.96x |
| 2026-01-02 | 43.21x |
| 2025-12-31 | 43.60x |
| 2025-12-30 | 43.83x |
| 2025-12-29 | 43.71x |
| 2025-12-26 | 43.90x |
| 2025-12-24 | 43.88x |
| 2025-12-23 | 44.02x |
| 2025-12-22 | 44.46x |
| 2025-12-19 | 43.96x |
| 2025-12-18 | 43.83x |
| 2025-12-17 | 43.84x |
| 2025-12-16 | 43.18x |
| 2025-12-15 | 43.40x |
| 2025-12-12 | 43.65x |
| 2025-12-11 | 43.67x |
| 2025-12-10 | 43.04x |
| 2025-12-09 | 42.02x |
| 2025-12-08 | 41.81x |
| 2025-12-05 | 43.34x |
| 2025-12-04 | 43.23x |
| 2025-12-03 | 42.72x |
| 2025-12-02 | 42.65x |
| 2025-12-01 | 43.41x |
| 2025-11-28 | 43.67x |
| 2025-11-26 | 43.67x |
| 2025-11-25 | 43.80x |
| 2025-11-24 | 42.73x |
| 2025-11-21 | 42.47x |
| 2025-11-20 | 40.34x |
| 2025-11-19 | 40.85x |
| 2025-11-18 | 40.88x |
| 2025-11-17 | 40.46x |
| 2025-11-14 | 40.84x |
| 2025-11-13 | 40.66x |
| 2025-11-12 | 41.02x |
| 2025-11-11 | 40.65x |
| 2025-11-10 | 40.15x |
| 2025-11-07 | 39.85x |
| 2025-11-06 | 39.32x |
| 2025-11-05 | 39.26x |
| 2025-11-04 | 39.36x |
| 2025-11-03 | 39.72x |
| 2025-10-31 | 39.76x |
| 2025-10-30 | 39.86x |
| 2025-10-29 | 39.60x |
| 2025-10-28 | 40.66x |
| 2025-10-27 | 41.19x |
| 2025-10-24 | 41.51x |
| 2025-10-23 | 42.01x |
| 2025-10-22 | 41.97x |
| 2025-10-21 | 42.24x |
| 2025-10-20 | 42.23x |
| 2025-10-17 | 40.76x |
| 2025-10-16 | 40.56x |
| 2025-10-15 | 39.20x |
| 2025-10-14 | 40.39x |
| 2025-10-13 | 39.46x |
| 2025-10-10 | 39.01x |
| 2025-10-09 | 39.68x |
| 2025-10-08 | 39.93x |
| 2025-10-07 | 39.33x |
| 2025-10-06 | 39.86x |
| 2025-10-03 | 40.03x |
| 2025-10-02 | 39.38x |
| 2025-10-01 | 38.86x |
| 2025-09-30 | 39.10x |
| 2025-09-29 | 38.67x |
| 2025-09-26 | 38.61x |
| 2025-09-25 | 38.29x |
| 2025-09-24 | 39.00x |
| 2025-09-23 | 38.59x |
| 2025-09-22 | 38.83x |
| 2025-09-19 | 38.91x |
| 2025-09-18 | 38.45x |
| 2025-09-17 | 37.04x |
| 2025-09-16 | 37.45x |
| 2025-09-15 | 37.60x |
| 2025-09-12 | 38.19x |
| 2025-09-11 | 39.05x |
| 2025-09-10 | 38.66x |
| 2025-09-09 | 38.95x |
| 2025-09-08 | 39.22x |
| 2025-09-05 | 38.87x |
| 2025-09-04 | 38.83x |
| 2025-09-03 | 38.41x |
| 2025-09-02 | 37.53x |
| 2025-08-29 | 38.54x |
| 2025-08-28 | 37.16x |
| 2025-08-27 | 47.40x |
| 2025-08-26 | 47.15x |
| 2025-08-25 | 47.05x |
| 2025-08-22 | 48.01x |
| 2025-08-21 | 46.81x |
| 2025-08-20 | 47.06x |
| 2025-08-19 | 47.35x |
| 2025-08-18 | 47.08x |
| 2025-08-15 | 46.93x |
| 2025-08-14 | 47.03x |
| 2025-08-13 | 47.49x |
| 2025-08-12 | 46.62x |
| 2025-08-11 | 45.63x |
| 2025-08-08 | 45.30x |
| 2025-08-07 | 44.71x |
| 2025-08-06 | 44.11x |
| 2025-08-05 | 44.90x |
| 2025-08-04 | 45.94x |
| 2025-08-01 | 45.62x |
| 2025-07-31 | 45.52x |
| 2025-07-30 | 46.39x |
| 2025-07-29 | 47.17x |
| 2025-07-28 | 46.74x |
| 2025-07-25 | 47.66x |
| 2025-07-24 | 47.23x |
| 2025-07-23 | 47.00x |
| 2025-07-22 | 46.81x |
| 2025-07-21 | 45.87x |
| 2025-07-18 | 46.59x |
| 2025-07-17 | 46.93x |
| 2025-07-16 | 46.63x |
| 2025-07-15 | 46.35x |
| 2025-07-14 | 47.12x |
| 2025-07-11 | 47.76x |
| 2025-07-10 | 48.82x |
| 2025-07-09 | 47.86x |
| 2025-07-08 | 47.48x |
| 2025-07-07 | 46.95x |
| 2025-07-03 | 46.95x |
| 2025-07-02 | 46.80x |
| 2025-07-01 | 46.69x |
| 2025-06-30 | 45.78x |
| 2025-06-27 | 45.77x |
| 2025-06-26 | 44.97x |
| 2025-06-25 | 44.89x |
| 2025-06-24 | 45.65x |
| 2025-06-23 | 44.88x |
| 2025-06-20 | 44.85x |
| 2025-06-18 | 45.04x |
| 2025-06-17 | 44.46x |
| 2025-06-16 | 45.00x |
| 2025-06-13 | 44.98x |
| 2025-06-12 | 45.63x |
| 2025-06-11 | 45.92x |
| 2025-06-10 | 46.62x |
| 2025-06-09 | 46.22x |
| 2025-06-06 | 46.42x |
| 2025-06-05 | 45.79x |
| 2025-06-04 | 43.73x |
| 2025-06-03 | 43.45x |
| 2025-06-02 | 43.50x |
Showing the most recent 260 of 4,531 data points. The chart above shows the full history.
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White